• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一份用于测量肠易激综合征患者生活质量的问卷。

Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome.

作者信息

Wong E, Guyatt G H, Cook D J, Griffith L E, Irvine E J

机构信息

Department of Medicine, University of Alberta, Edmonton, Canada.

出版信息

Eur J Surg Suppl. 1998(583):50-6. doi: 10.1080/11024159850191247.

DOI:10.1080/11024159850191247
PMID:10027673
Abstract

OBJECTIVE

To develop a questionnaire for measuring health-related quality of life (HRQL) in patients with Irritable Bowel Syndrome (IBS).

METHODS

We surveyed the existing literature, and interviewed patients and clinicians, to develop a list of 182 potential problems for IBS patients. One hundred patients with IBS completed a questionnaire in which they told us whether each of the 182 items was a problem for them, and if so the magnitude of their importance in their lives.

RESULTS

Patients identified four major problem areas: bowel symptoms, fatigue, activity limitations, and emotional dysfunction. On the basis of these findings, we constructed a 26-item questionnaire which, in pre-testing, 16 patients found clear and easy to complete.

CONCLUSION

We have developed a questionnaire that measures HRQL in IBS patients and is suitable for use as an outcome measure in clinical trials in IBS.

摘要

目的

编制一份用于测量肠易激综合征(IBS)患者健康相关生活质量(HRQL)的问卷。

方法

我们查阅了现有文献,并采访了患者和临床医生,以列出182个IBS患者可能存在的问题。100名IBS患者完成了一份问卷,在问卷中他们告知我们这182个项目中的每一项是否是他们面临的问题,如果是,该问题在他们生活中的重要程度。

结果

患者确定了四个主要问题领域:肠道症状、疲劳、活动受限和情绪功能障碍。基于这些发现,我们编制了一份包含26个条目的问卷,在预测试中,16名患者认为该问卷清晰且易于填写。

结论

我们编制了一份可测量IBS患者HRQL的问卷,适用于作为IBS临床试验的结局指标。

相似文献

1
Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome.开发一份用于测量肠易激综合征患者生活质量的问卷。
Eur J Surg Suppl. 1998(583):50-6. doi: 10.1080/11024159850191247.
2
Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.肠易激综合征对美国和英国生活质量及资源利用的影响。
Digestion. 1999 Jan-Feb;60(1):77-81. doi: 10.1159/000007593.
3
Towards a better understanding of patients with irritable bowel syndrome.
J Adv Nurs. 1993 Sep;18(9):1443-50. doi: 10.1046/j.1365-2648.1993.18091443.x.
4
Sense of coherence and quality of life in women with and without irritable bowel syndrome.伴有和不伴有肠易激综合征的女性的连贯感和生活质量
Nurs Res. 2003 Sep-Oct;52(5):329-37. doi: 10.1097/00006199-200309000-00007.
5
Impact of irritable bowel syndrome on patients' lives: development and psychometric documentation of a disease-specific measure for use in clinical trials.肠易激综合征对患者生活的影响:一种用于临床试验的疾病特异性测量方法的开发及心理测量学记录
Eur J Gastroenterol Hepatol. 2005 Apr;17(4):411-20. doi: 10.1097/00042737-200504000-00004.
6
Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.转诊中心与初级保健机构中肠易激综合征患者的生活质量:性别和主要排便模式的影响。
Scand J Gastroenterol. 2001 May;36(5):545-52. doi: 10.1080/003655201750153476.
7
Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome.一种用于肠易激综合征患者的新型生活质量问卷的评估
Aliment Pharmacol Ther. 1997 Jun;11(3):547-52. doi: 10.1046/j.1365-2036.1997.00168.x.
8
The IBS-36: a new quality of life measure for irritable bowel syndrome.IBS-36:一种用于肠易激综合征的新的生活质量测量方法。
Am J Gastroenterol. 2002 Apr;97(4):962-71. doi: 10.1111/j.1572-0241.2002.05616.x.
9
Quality of life in irritable bowel syndrome, effect of therapy.肠易激综合征的生活质量及治疗效果
Eur J Surg Suppl. 1998(583):81-6. doi: 10.1080/11024159850191300.
10
Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?基层医疗中肠易激综合征患者与门诊肠易激综合征患者真的存在差异吗?
Gut. 1997 Nov;41(5):669-74. doi: 10.1136/gut.41.5.669.

引用本文的文献

1
The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.异体与自体粪便微生物群移植对肠易激综合征症状、内脏感知及粪便和黏膜微生物群的影响:一项随机对照研究。
Clin Transl Gastroenterol. 2019 Apr;10(4):e00034. doi: 10.14309/ctg.0000000000000034.
2
A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.对测量肠易激综合征患者健康相关生活质量的工具的测量属性进行的系统评价。
Qual Life Res. 2016 Dec;25(12):2985-2995. doi: 10.1007/s11136-016-1421-4. Epub 2016 Sep 29.
3
Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation.
肠易激综合征特异性健康相关生活质量量表:编制与心理测量学评价
Health Qual Life Outcomes. 2016 Feb 17;14:22. doi: 10.1186/s12955-016-0423-9.
4
Irritable bowel syndrome: dietary interventions.肠易激综合征:饮食干预措施
BMJ Clin Evid. 2015 Jul 30;2015:0410.
5
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.肠易激综合征:一种仍在探寻发病机制、诊断方法及治疗手段的疾病。
World J Gastroenterol. 2014 Jul 21;20(27):8807-20. doi: 10.3748/wjg.v20.i27.8807.
6
Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory.慢性病患者生活质量测定量表体系下肠易激综合征量表(QLICD-IBS)的研制与考评:经典测量理论与概化理论的结合
Int J Colorectal Dis. 2014 Oct;29(10):1245-55. doi: 10.1007/s00384-014-1976-x. Epub 2014 Aug 1.
7
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.开发一个在线胃肠道患者报告结局测量库:GI-PRO 数据库。
Am J Gastroenterol. 2014 Feb;109(2):234-48. doi: 10.1038/ajg.2013.401. Epub 2013 Dec 17.
8
Patient-reported outcomes in gastroenterology: clinical and research applications.胃肠病学中的患者报告结局:临床和研究应用。
J Neurogastroenterol Motil. 2013 Apr;19(2):137-48. doi: 10.5056/jnm.2013.19.2.137. Epub 2013 Apr 16.
9
Irritable bowel syndrome.肠易激综合征
BMJ Clin Evid. 2012 Jan 6;2012:0410.
10
A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.一项双盲安慰剂对照试验,旨在研究益生菌大肠杆菌 Nissle 1917 对肠易激综合征患者亚组的治疗效果。
Int J Colorectal Dis. 2012 Apr;27(4):467-74. doi: 10.1007/s00384-011-1363-9. Epub 2011 Dec 2.